Since Bik can either act as a pro-apoptotic or anti-apoptotic regulator and was previously shown to be highly expressed in breast cancer cell lines, further studies are required to pinpoint the effect of the differential regulation of Bik when treated with test compounds. Here, BIK is linked to breast carcinoma.